Atlas Trials

Atrial Fibrillation in Patients Receiving Ibrutinib

Clinical trial NCT04407845 · UNKNOWN

Trial details

NCT number
NCT04407845
Sponsor
European Georges Pompidou Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Leukemia, Chronic LymphaticMantle Cell Lymphoma
Start date
2020-05-21
Primary completion
2022-05-21
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.